Neurones S.A. (EPA:NRO)
France flag France · Delayed Price · Currency is EUR
34.60
-1.60 (-4.42%)
At close: Mar 13, 2026

Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of EUR 841.24 million. The enterprise value is 654.48 million.

Market Cap841.24M
Enterprise Value 654.48M

Important Dates

The last earnings date was Wednesday, March 11, 2026.

Earnings Date Mar 11, 2026
Ex-Dividend Date Jun 11, 2025

Share Statistics

Neurones has 24.31 million shares outstanding.

Current Share Class 24.31M
Shares Outstanding 24.31M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 4.41%
Owned by Institutions (%) 6.98%
Float 12.07M

Valuation Ratios

The trailing PE ratio is 16.15 and the forward PE ratio is 14.71.

PE Ratio 16.15
Forward PE 14.71
PS Ratio 0.98
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 12.56
EV / Sales 0.76
EV / EBITDA 7.73
EV / EBIT 8.66
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 59.63%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 6.95%
Revenue Per Employee 119,254
Profits Per Employee 7,248
Employee Count7,188
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Neurones has paid 23.20 million in taxes.

Income Tax 23.20M
Effective Tax Rate 27.26%

Stock Price Statistics

The stock price has decreased by -27.16% in the last 52 weeks. The beta is 0.49, so Neurones's price volatility has been lower than the market average.

Beta (5Y) 0.49
52-Week Price Change -27.16%
50-Day Moving Average 38.11
200-Day Moving Average 41.36
Relative Strength Index (RSI) 41.98
Average Volume (20 Days) 15,830

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Neurones had revenue of EUR 857.20 million and earned 52.10 million in profits.

Revenue857.20M
Gross Profit 857.20M
Operating Income 75.60M
Pretax Income 85.10M
Net Income 52.10M
EBITDA 84.69M
EBIT 75.60M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 8.82% and 6.08%.

Gross Margin 100.00%
Operating Margin 8.82%
Pretax Margin 9.93%
Profit Margin 6.08%
EBITDA Margin 9.88%
EBIT Margin 8.82%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 4.05%.

Dividend Per Share 1.40
Dividend Yield 4.05%
Dividend Growth (YoY) 8.33%
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 4.05%
Earnings Yield 6.19%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2